This inventor holds 2 USPTO granted patents. Top assignee: Taiyo Kagaku Co., Ltd.. Active years: 1993-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1998
Title: Hiroshi Kawanami: Innovator in Sialic Acid Production
Introduction
Hiroshi Kawanami is an accomplished inventor based in Yokkaichi, Japan, known for his significant contributions in the field of pharmaceutical compositions. With a total of two patents to his name, Kawanami has made strides in the production and purification of sialic acid, an important component in various pharmaceutical applications.
Latest Patents
Kawanami's latest innovations include a pharmaceutical composition containing sialic acid derivatives and a method for the production of sialic acid. His invention regarding the production method directs attention to a unique process that involves hydrolysis of delipidated egg yolk. This method allows for the extraction and purification of high purity sialic acid on an industrial scale, involving steps such as desalting a solution and adsorbing the acid to an anion exchange resin.
Career Highlights
Hiroshi Kawanami is affiliated with Taiyo Kagaku Co., Ltd., a company recognized for its advancements in the life sciences sector. His work at this esteemed organization underscores the significant impact of his research on industrial applications and the pharmaceutical field.
Collaborations
Kawanami has collaborated with distinguished coworkers, including Mamoru Koketsu and Lekh Raj Juneja. Their collective expertise in research and development has contributed to the innovative strides made in the pharmaceutical applications of sialic acid.
Conclusion
Hiroshi Kawanami's continued efforts in innovation highlight his role as a valuable inventor in the pharmaceutical industry. His research not only advances scientific knowledge but also facilitates the industrial-scale production and purification of essential compounds, promising improved outcomes in healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile